Anupam Rama
Stock Analyst at J.P. Morgan
(4.88)
# 321
Out of 4,690 analysts
777
Total ratings
53.9%
Success rate
22.8%
Average return
Main Sectors:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZLAB Zai Lab | Rated: Buy | $27 → $36 | $26.08 | +38.04% | 22 | Aug 27, 2026 | |
| ERAS Erasca | Rated: Buy | $25 → $33 | $18.03 | +83.03% | 13 | Aug 27, 2026 | |
| REPL Replimune Group | Rated: Buy | $20 → $21 | $15.50 | +35.48% | 35 | Aug 26, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Buy | $80 | $25.61 | +212.38% | 31 | Aug 25, 2026 | |
| KARD Kardigan | Rated: Buy | $51 → $46 | $20.02 | +129.77% | 2 | Aug 25, 2026 | |
| TRAX First Tracks Biotherapeutics | Maintained: Buy | $30 → $65 | $41.86 | +55.28% | 4 | Aug 19, 2026 | |
| CTMX CytomX Therapeutics | Maintained: Buy | $11 | $3.21 | +242.68% | 14 | Aug 17, 2026 | |
| OLMA Olema Pharmaceuticals | Maintained: Buy | $46 | $10.27 | +347.91% | 31 | Aug 17, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | $86 → $76 | $34.19 | +122.29% | 33 | Aug 17, 2026 | |
| PROK ProKidney | Maintained: Hold | n/a | $1.83 | - | 6 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $100 → $111 | $76.60 | +44.91% | 43 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $40 | $19.54 | +104.71% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $9.77 | +12.59% | 17 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $62 | $40.11 | +54.57% | 38 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $217 | $154.06 | +40.85% | 66 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $90 | $65.67 | +37.05% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $13.24 | +73.72% | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $56 → $66 | $37.72 | +74.97% | 22 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $72 → $107 | $78.08 | +37.04% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 | $4.15 | +116.87% | 3 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $3.85 | - | 5 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $34.67 | - | 16 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 → $70 | $56.28 | +24.38% | 34 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $53 | $27.44 | +93.15% | 11 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $19 | $20.86 | -8.92% | 63 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.73 | - | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.97 | - | 20 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $13.60 | +39.71% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $13.17 | +142.98% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $22.65 | +76.60% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 | $9.26 | -35.21% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.81 | n/a | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $204 → $170 | $237.10 | n/a | 14 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.03 | n/a | 11 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $5 | $9.20 | n/a | 6 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $64 | $72.09 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $26 | $1.74 | n/a | 6 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $48 | $33.32 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $90.36 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $45 | $144.33 | n/a | 6 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.52 | n/a | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $17.05 | n/a | 7 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $57.80 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $30 → $37 | $10.83 | n/a | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $0.0001 | n/a | 8 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $56 → $10 | $12.91 | n/a | 5 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $25.07 | n/a | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $2.23 | n/a | 2 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $46.48 | n/a | 9 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $70.09 | n/a | 10 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $157.15 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $4.13 | n/a | 10 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.44 | n/a | 4 | Jun 15, 2016 |
Zai Lab
Aug 27, 2026
Rated: Buy
Price Target: $27 → $36
Current: $26.08
Upside: +38.04%
Erasca
Aug 27, 2026
Rated: Buy
Price Target: $25 → $33
Current: $18.03
Upside: +83.03%
Replimune Group
Aug 26, 2026
Rated: Buy
Price Target: $20 → $21
Current: $15.50
Upside: +35.48%
Ultragenyx Pharmaceutical
Aug 25, 2026
Rated: Buy
Price Target: $80
Current: $25.61
Upside: +212.38%
Kardigan
Aug 25, 2026
Rated: Buy
Price Target: $51 → $46
Current: $20.02
Upside: +129.77%
First Tracks Biotherapeutics
Aug 19, 2026
Maintained: Buy
Price Target: $30 → $65
Current: $41.86
Upside: +55.28%
CytomX Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $11
Current: $3.21
Upside: +242.68%
Olema Pharmaceuticals
Aug 17, 2026
Maintained: Buy
Price Target: $46
Current: $10.27
Upside: +347.91%
Vera Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $86 → $76
Current: $34.19
Upside: +122.29%
ProKidney
Aug 13, 2026
Maintained: Hold
Price Target: n/a
Current: $1.83
Upside: -
Aug 12, 2026
Rated: Buy
Price Target: $100 → $111
Current: $76.60
Upside: +44.91%
Aug 11, 2026
Maintained: Buy
Price Target: $45 → $40
Current: $19.54
Upside: +104.71%
Aug 11, 2026
Maintained: Buy
Price Target: $11
Current: $9.77
Upside: +12.59%
Aug 10, 2026
Maintained: Buy
Price Target: $66 → $62
Current: $40.11
Upside: +54.57%
Aug 6, 2026
Maintained: Buy
Price Target: $217
Current: $154.06
Upside: +40.85%
Aug 6, 2026
Maintained: Buy
Price Target: $53 → $90
Current: $65.67
Upside: +37.05%
Aug 6, 2026
Maintained: Buy
Price Target: $23
Current: $13.24
Upside: +73.72%
Aug 3, 2026
Rated: Buy
Price Target: $56 → $66
Current: $37.72
Upside: +74.97%
Jul 29, 2026
Rated: Buy
Price Target: $72 → $107
Current: $78.08
Upside: +37.04%
Jun 22, 2026
Upgraded: Buy
Price Target: $9
Current: $4.15
Upside: +116.87%
Jun 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $3.85
Upside: -
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $34.67
Upside: -
May 22, 2026
Maintained: Buy
Price Target: $69 → $70
Current: $56.28
Upside: +24.38%
May 22, 2026
Maintained: Buy
Price Target: $58 → $53
Current: $27.44
Upside: +93.15%
May 18, 2026
Maintained: Hold
Price Target: $18 → $19
Current: $20.86
Upside: -8.92%
Mar 24, 2026
Maintained: Sell
Price Target: n/a
Current: $1.73
Upside: -
Mar 18, 2026
Maintained: Buy
Price Target: n/a
Current: $4.97
Upside: -
Mar 3, 2026
Maintained: Buy
Price Target: $19
Current: $13.60
Upside: +39.71%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $13.17
Upside: +142.98%
Dec 18, 2025
Maintained: Buy
Price Target: $40
Current: $22.65
Upside: +76.60%
Nov 18, 2025
Maintained: Sell
Price Target: $6
Current: $9.26
Upside: -35.21%
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $16.81
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $204 → $170
Current: $237.10
Upside: n/a
Dec 22, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.03
Upside: n/a
Aug 15, 2022
Maintained: Hold
Price Target: $27 → $5
Current: $9.20
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $55 → $64
Current: $72.09
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $31 → $26
Current: $1.74
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $50 → $48
Current: $33.32
Upside: n/a
May 10, 2022
Maintained: Buy
Price Target: $9 → $8
Current: $90.36
Upside: n/a
May 6, 2022
Maintained: Buy
Price Target: $51 → $45
Current: $144.33
Upside: n/a
Mar 8, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.52
Upside: n/a
Feb 25, 2022
Maintained: Hold
Price Target: $12 → $13
Current: $17.05
Upside: n/a
Nov 12, 2021
Maintained: Buy
Price Target: $55
Current: $57.80
Upside: n/a
Oct 25, 2021
Upgraded: Hold
Price Target: $30 → $37
Current: $10.83
Upside: n/a
Aug 5, 2021
Upgraded: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Mar 25, 2021
Downgraded: Sell
Price Target: $56 → $10
Current: $12.91
Upside: n/a
Oct 12, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $25.07
Upside: n/a
Jun 5, 2019
Downgraded: Sell
Price Target: n/a
Current: $2.23
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $7 → $6
Current: $46.48
Upside: n/a
Nov 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $70.09
Upside: n/a
Sep 29, 2017
Maintained: Hold
Price Target: n/a
Current: $157.15
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $20 → $19
Current: $4.13
Upside: n/a
Jun 15, 2016
Maintained: Hold
Price Target: n/a
Current: $17.44
Upside: n/a